𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Risks and Benefits of Infliximab for the Treatment of Crohn’s Disease

✍ Scribed by Siegel, Corey A.; Hur, Chin; Korzenik, Joshua R.; Gazelle, G. Scott; Sands, Bruce E.

Book ID
121398914
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
239 KB
Volume
4
Category
Article
ISSN
1542-3565

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Patient perceptions of the risks and ben
Patient perceptions of the risks and benefits of infliximab for the treatment of inflammatory bowel disease
✍ Corey A. Siegel; L. Campbell Levy; Todd A. MacKenzie; Bruce E. Sands 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 360 KB 👁 2 views

Background: For a patient to make informed, preference based decisions, they must be able to balance the risks and benefits of treatment. The aim of this study was to determine patients' and parents' perceptions of the risks and benefits of infliximab for the treatment of inflammatory bowel disease